Is Journey Medical Corp (DERM) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 9.7% / 30% | 7.9% / 30% | 4.0% / 30% | 1.35% / 5% | ✓ HALAL |
| DJIM | 9.7% / 33% | 7.9% / 33% | 4.0% / 33% | 1.35% / 5% | ✓ HALAL |
| MSCI | 31.3% / 33% | 25.3% / 33% | 12.8% / 33% | 1.35% / 5% | ✓ HALAL |
| S&P | 9.7% / 33% | 7.9% / 33% | 4.0% / 33% | 1.35% / 5% | ✓ HALAL |
| FTSE | 31.3% / 33% | 25.3% / 33% | 12.8% / 50% | 1.35% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 66.2% | |
| Operating Margin | -2.8% | |
| Net Margin | -18.5% | |
| Return on Equity (ROE) | -44.0% | |
| Return on Assets (ROA) | -5.8% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$9M |
| Free Cash Flow | -$24M |
| Total Debt | $25M |
| Debt-to-Equity | 79.7 |
| Current Ratio | 1.8 |
| Total Assets | $80M |
Price & Trading
| Last Close | $4.78 |
| 50-Day MA | $7.94 |
| 200-Day MA | $7.59 |
| Avg Volume | 139K |
| Beta | 0.8 |
|
52-Week Range
$4.51
| |
About Journey Medical Corp (DERM)
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also provides Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Emrosi for the treatment of inflammatory lesions of rosacea; Exelderm cream and solution for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
Purification Calculator
As a halal stock with 1.35% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Journey Medical Corp (DERM) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Journey Medical Corp is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Journey Medical Corp's debt ratio?
Journey Medical Corp's debt ratio is 9.7% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 31.3%.
Does Journey Medical Corp require dividend purification?
Yes, Journey Medical Corp has an impermissible income ratio of 1.35%, which means 1.35% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are Journey Medical Corp's key financial metrics?
Journey Medical Corp has a market capitalization of $152M, and revenue of $56M. The company maintains a gross margin of 66.2% and a net margin of -18.5%. Return on equity stands at -44.0%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.